Antischizophrenic drugs: Differential plasma protein binding and therapeutic activity

This publication has 24 references indexed in Scilit:

• Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine
  American Journal of Psychiatry, 1977
• Plasma binding and the affinity of propranolol for a beta receptor in man
  Clinical Pharmacology & Therapeutics, 1976
• Clinical significance of plasma chlorpromazine levels I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment
  Psychological Medicine, 1976
• Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels
  American Journal of Psychiatry, 1976
• Effects of chlorpromazine and three metabolites on behavioral responses in rats
  Psychopharmacology, 1974
• Physiologic and clinical effects of chlorpromazine and their relationship to plasma level
  Clinical Pharmacology & Therapeutics, 1972
• Plasma protein binding of chlorpromazine
  Journal of Pharmacy and Pharmacology, 1970
• Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma by using gas-liquid chromatography with an electron capture detector
  Analytical Chemistry, 1968
• Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients
  Life Sciences, 1967
• A comparative pharmacological study of a series of monohydroxylated and methoxylated chlorpromazine derivatives
  Life Sciences, 1965